Skip to main navigation Skip to search Skip to main content

Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma

  • Jonathan Y. Xia
  • , Srinadh Komanduri
  • , Rajesh N. Keswani
  • , Terrance R. Rodrigues
  • , Jasmine Sinha
  • , Arvind Rengarajan
  • , Peter Tran
  • , Chelsea Hepler
  • , Arthur Prindle
  • , A. Aziz Aadam

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Cholangiocarcinoma (CCA) is an aggressive cancer with a poor prognosis. Histopathology evaluation of brushings and biopsies obtained during endoscopic retrograde cholangiopancreatography (ERCP) currently remains the main method of diagnosis, which has limited sensitivity for malignancy detection. Our study aimed to identify human bile-derived biomarkers to improve CCA diagnosis. Bile samples were collected from patients during ERCP for primary sclerosing cholangitis, CCA, or benign biliary disease. Methods: Bile samples were collected from patients undergoing ERCP for biliary obstruction due to primary sclerosing cholangitis, newly identified malignant strictures concerning for CCA, or benign biliary disease. Using 16S sequencing, metabolomics, and bile acid quantification, we aimed to identify distinctive microbial and metabolite signatures associated with CCA. Results: Multi-omics analyses revealed distinct microbial and metabolite signatures associated with CCA. From these findings, we identified and validated microbial and metabolite markers capable of accurately detecting CCA with improved sensitivity and specificity for malignancy detection compared to current cytology-based methods. Conclusions: These findings highlight the potential of multi-omics bile–based diagnostic panels to enhance endoscopic detection of biliary malignancies, offering a promising tool for evaluating indeterminate biliary strictures and advancing precision in ERCP diagnostics.

Original languageEnglish
Article numbere0786
JournalHepatology Communications
Volume9
Issue number9
DOIs
StatePublished - Sep 1 2025

Keywords

  • ERCP
  • cholangiocarcinoma
  • indeterminate biliary strictures
  • metabolomics
  • microbiome
  • primary sclerosing cholangitis

Fingerprint

Dive into the research topics of 'Integrating multi-omics in bile for biomarker discovery in cholangiocarcinoma'. Together they form a unique fingerprint.

Cite this